TMCI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Treace Medical Concepts, Inc (TMCI) is not a good buy for a beginner, long-term investor at this time. The stock lacks strong positive catalysts, has mixed financial performance, and analysts have lowered price targets with neutral to hold ratings. Additionally, there are no significant trading signals or influential figure activity to support a buy decision.
The MACD is positive and contracting, indicating a potential weakening of upward momentum. RSI is neutral at 56.546, and moving averages are converging, suggesting no clear trend. Key support and resistance levels show limited upside potential with resistance at 2.155 and support at 1.402.
NULL identified. No recent news or significant trading trends from insiders or hedge funds.
Analysts have lowered price targets and expressed concerns about growth re-acceleration. Q4 financials show a YoY revenue decline and gross margin contraction. Lack of recent congress trading data or influential figure activity.
In 2025/Q4, revenue dropped by -9.01% YoY to $62.52M. Net income improved significantly YoY but remains negative at -$9.39M. EPS increased to -0.15, but gross margin slightly declined to 80.62%.
Analysts have lowered price targets (e.g., UBS to $2.25, Truist to $2) and maintain neutral or hold ratings. They cite concerns about growth and product mix shifts.
